Influence of demographic and tumour variables on prostate cancer treatment with curative intent in Spain. Results of the 2010 national prostate cancer registry

被引:1
作者
Martinez-Jabaloyas, J. M. [1 ]
Castello-Porcar, A. [1 ]
Gonzalez-Baena, A. C. [2 ]
Cozar-Olmo, J. M. [3 ]
Minana-Lopez, B. [4 ]
Gomez-Veiga, F. [5 ]
Rodriguez-Antolin, A. [6 ]
机构
[1] Hosp Clin Univ, Serv Urol, Valencia, Spain
[2] Hosp Virgen de la Macarena, Serv Urol, Seville, Spain
[3] Hosp Virgen de la Nieves, Serv Urol, Granada, Spain
[4] Hosp Morales Meseguer, Serv Urol, Murcia, Spain
[5] Hosp Univ Salamanca, Serv Urol, CHUAC, Salamanca, Spain
[6] Hosp Gregorio Maranon, Serv Urol, Madrid, Spain
来源
ACTAS UROLOGICAS ESPANOLAS | 2016年 / 40卷 / 08期
关键词
Prostate cancer; Treatment; Surgery; Radical prostatectomy; Radiation therapy; Brachytherapy; RADICAL PROSTATECTOMY; BRACHYTHERAPY; MEN; RECOMMENDATIONS; FEASIBILITY; THERAPY; AGE;
D O I
10.1016/j.acuro.2016.04.011
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim of this study is to determine which cancer and demographic criteria influence the indication for surgery (radical prostatectomy) or radiation therapy (external or brachytherapy) in the treatment of prostate cancer. Material and methods: An analysis of the 2714 patients of the 2010 National Prostate Cancer Registry treated with curative intent. The analysed variables were age, prostate-specific antigen (PSA), prostate volume, the number of biopsy cores, the percentage of positive cores, the stage, Gleason score, the type of pathologist, the presence of perineural invasion and the study centre. We analysed the association among these variables and the type of treatment (surgery vs. radiation therapy/brachytherapy), using a univariate analysis (Student's t test and chi-squared) and a binary multiple logistic regression. Results: The 48.12% of the patients (1306/2714) were treated with surgery, and 51.88% (1,408/2,714) underwent radiation therapy/brachytherapy. Differences were observed between the patients treated with prostatectomy and those treated with radiation therapy/brachytherapy (p<.05) in age (63.50 +/- 6.5 vs. 69.0 +/- 6.7), PSA (8.76 +/- 16.97 vs. 13.21 +/- 15.88), biopsied cores, percentage of positives cores (30.0 +/- 22 vs. 38.7 +/- 29), Gleason score (G6: 53.9% vs. 46.1%; G7: 45% vs. 55% G8-10: 26.6%, 73.4%), stage (localised: 50% vs. 50%; locally advanced: 14.6% vs. 85.4%), perineural invasion and hospital centre. In the multivariate analysis, the selected independent variables were age, PSA, percentage of positives cores, stage, Gleason score and hospital centre. Conclusion: According to our study, age, tumour aggressiveness and stage and the centre where the patient will be treated affect the selection of curative treatment for prostate cancer. (C) 2016 AEU. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:485 / 491
页数:7
相关论文
共 32 条
[1]   Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer [J].
Bill-Axelson, Anna ;
Holmberg, Lars ;
Garmo, Hans ;
Rider, Jennifer R. ;
Taari, Kimmo ;
Busch, Christer ;
Nordling, Stig ;
Haggman, Michael ;
Andersson, Swen-Olof ;
Spangberg, Anders ;
Andren, Ove ;
Palmgren, Juni ;
Steineck, Gunnar ;
Adami, Hans-Olov ;
Johansson, Jan-Erik .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (10) :932-942
[2]   Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) [J].
Bolla, Michel ;
van Poppel, Hein ;
Tombal, Bertrand ;
Vekemans, Kris ;
Da Pozzo, Luigi ;
de Reijke, Theo M. ;
Verbaeys, Antony ;
Bosset, Jean-Francois ;
van Velthoven, Roland ;
Colombel, Marc ;
van de Beek, Cees ;
Verhagen, Paul ;
van den Bergh, Alphonsus ;
Sternberg, Cora ;
Gasser, Thomas ;
van Tienhoven, Geertjan ;
Scalliet, Pierre ;
Haustermans, Karin ;
Collette, Laurence .
LANCET, 2012, 380 (9858) :2018-2027
[3]   Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer [J].
Cooperberg, Matthew R. ;
Broering, Jeanette M. ;
Carroll, Peter R. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) :1117-1123
[4]   National Prostate Cancer Registry 2010 in Spain [J].
Cozar, J. M. ;
Minana, B. ;
Gomez-Veiga, F. ;
Rodriguez-Antolin, A. ;
Villavicencio, H. ;
Cantalapiedra, A. ;
Pedrosa, E. .
ACTAS UROLOGICAS ESPANOLAS, 2013, 37 (01) :12-19
[5]   Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study [J].
Culp, Stephen H. ;
Schellhammer, Paul F. ;
Williams, Michael B. .
EUROPEAN UROLOGY, 2014, 65 (06) :1058-1066
[6]  
Diefenbach Michael A, 2002, Semin Urol Oncol, V20, P55, DOI 10.1053/suro.2002.30399
[7]   SABRE 1 (Surgery Against Brachytherapy - a Randomised Evaluation): feasibility randomised controlled trial (RCT) of brachytherapy vs radical prostatectomy in low-intermediate risk clinically localised prostate cancer [J].
Eccles, Bryony K. ;
Cross, William ;
Rosario, Derek J. ;
Doble, Andrew ;
Parker, Chris ;
Logue, John ;
Little, Louisa ;
Stanton, Louise ;
Bottomley, David .
BJU INTERNATIONAL, 2013, 112 (03) :330-337
[8]  
Ferrandis C, 2011, ACTAS UROL ESP, V35, P146, DOI [10.1016/S2173-5786(11)70039-7, 10.1016/j.acuro.2010.08.006]
[9]   Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer [J].
Fowler, FJ ;
Collins, MM ;
Albertsen, PC ;
Zietman, A ;
Elliott, DB ;
Barry, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (24) :3217-3222
[10]   Prostate cancer treatment in Europe at the end of 1990s [J].
Gatta, Gemma ;
Zigon, Giulia ;
Buemi, Antoine ;
Coebergh, Jan Willem ;
Colonna, Marc ;
Contiero, Paolo ;
Denis, Louis ;
Grosclaude, Pascale ;
Guizard, Ann Valerie ;
Jose Sanchez-Perez, Maria ;
Plesko, Ivan ;
Ondrusova, Martina ;
Rachtan, Jadwiga ;
Valdagni, Riccardo ;
Velten, Michael ;
Vercelli, Marina ;
Berrino, Franco .
ACTA ONCOLOGICA, 2009, 48 (06) :867-873